Matt Davis | Senior Director, Molecular Biology and Sequencing
Gritstone Bio

Matt Davis, Senior Director, Molecular Biology and Sequencing, Gritstone Bio

Matthew Davis PhD joined Gritstone Bio (NASDAQ: GRTS) in 2015 and is currently the Senior Director of Molecular Biology and Sequencing responsible for various neoantigen discovery and translational genomics efforts.  Prior to Gritstone, Dr. Davis conducted post-doctoral research at Warp Drive Bio in the discovery biology group.  He holds a PhD in Genetics from Yale with thesis research under the supervision of Dr. Joseph Schlessinger and before his graduate work he conducted cancer genomics research at Dana Farber Cancer Institute and the Broad Institute.


Day 2 - November 29 @ 09:15

Keynote Panel: Moving to the left: The maturing applications of ct & cf DNA in oncology

  • What progress has been made? Recent approvals.
  • As yet untapped potential uses of ctDNA in oncology
  • Success in prediction but difficulty of use in later stage development
  • Do certain phenotypes amongst circulating immune cells dictate responsiveness to certain IO drugs or combinations?

Day 2 - November 29 @ 12:20

A cfDNA assay to monitor early escape

last published: 02/Jan/24 12:15 GMT

back to speakers